HCWB HCW Biologics Inc
Company Analysis
Latest News
🔴 HCW Biologics Inc is trading 11.6% down today amid Q1 2026 update and Nasdaq compliance concerns
HCW Biologics Inc is trading at $1.83 (11.6% down) following its recent first-quarter 2026 update and shifts in its capital structure. • The company is under...
🔴 HCW Biologics Inc is trading 12.09% down
HCWB is trading at $1.82, down 12.09%.
🔴 HCW Biologics Inc is trading 8% down today on dilution risk from warrant repricing
HCW Biologics Inc is trading 8% down today at $1.91 as investors react to dilution risks stemming from a warrant repricing and ongoing concerns regarding its...
HCW Biologics Dodges Delisting for Now, but Can a $2 Stock With No Revenue Buy Enough Time?
Shares of HCW Biologics (HCWB) ticked up 3.5% to $2.05 after the company disclosed that a Nasdaq Hearings Panel granted it additional time to regain compliance...
🟢 HCW Biologics Inc is trading 3.5% up today as Nasdaq extension eases delisting concerns
HCW Biologics Inc is trading 3.5% up today at $2.05 after disclosing that Nasdaq granted the company an extension to regain minimum bid-price compliance,...
🔴 HCWB is trading 5.26% down in after-hours
HCWB is trading at $1.98, down 5.26% in after-hours.
🟢 HCWB is trading 4.31% up in pre-market
HCWB is trading at $2.18, up 4.31% in pre-market.
🟢 HCWB is trading 6.2% up today as it rebounds after regaining rights to key molecules
HCWB is trading 6.2% up today at $2.06 as it rebounds from a sharp selloff on May 27, 2026, following the termination of its licensing agreement with Wugen. •...
🔴 HCWB is trading 22.7% down today after terminating its Wugen license agreement to regain rights to key molecules
HCWB is trading 22.7% down today at $2.02 after the company announced it has terminated an exclusive worldwide license agreement with Wugen to regain full ex...
🔴 HCWB is trading 9.9% down today after terminating its Wugen license deal to regain molecule rights
HCWB is trading approximately 9.9% down at $2.36 after announcing the termination of its exclusive worldwide license agreement with Wugen. • By ending the...
HCW Biologics Terminates Wugen Agreement, Regains Full Rights to Two Immunotherapeutics
HCW Biologics Inc. announced it has terminated its exclusive worldwide license agreement with Wugen Inc., regaining full ex vivo rights to its...
🔴 HCWB is trading 12.1% down today on profit-taking after a massive multi-session rally
HCWB is trading 12.1% down today at $2.54 as the stock enters a consolidation phase following a dramatic surge from $0.34 to the mid-$2 range. • The recent...
🟢 HCWB is trading 5% up today, extending recent rally driven by Q1 results and financing
HCWB is trading 5% up at $2.72 in pre-market, continuing a major rally that began in mid-May. • The surge appears driven by strong Q1 2026 financial results...
🟢 HCWB is trading 27% up today after $4M private placement and preclinical data
HCWB is trading at $3.26 (+26.53%) today after announcing a $4.0 million private placement and releasing positive preclinical data for its T-cell engager...
🟢 HCWB is trading 55% up today after a $4M private placement and promising preclinical data
HCWB is trading 55% up at $4.01 in pre-market trading, extending a significant two-day rally following key corporate updates. • The company secured a $4.0...
HCW Biologics Announces ~$4.0 Million Private Placement with Accredited Investors
HCW Biologics Inc. entered into a Securities Purchase Agreement with accredited investors to raise approximately $4.0 million in gross proceeds. The private...
HCW Biologics Raises $4 Million for Clinical Trials Following Triple-Digit Rally
HCW Biologics Inc. (NASDAQ: HCWB) priced an at-the-market private placement of 2,846,975 units to healthcare investors. The company raised approximately $4.0...
🔴 HCWB is trading 17.7% down today as momentum fades from its recent licensing deal rally amid broader market weakness
HCWB is trading 17.7% down at $2.00 as the stock pulls back from its prior session peak of $2.43 following a licensing-driven rally. • The decline follows a...
I need to research the latest news about HCW Biologics (HCWB) to get specific facts and figures for this briefing.
HCWB Soars 500% in a Week on CAR-T Buzz and a One-Time Deal — But Can a Company Running on Fumes Sustain It? Shares of HCW Biologics slipped 13.2% in...
🔴 HCWB is trading 9.5% down today on profit-taking after massive multi-day rally
HCWB is trading 9.5% down at $2.20 as momentum cools following an extreme multi-day rally. • Shares previously surged 129.25% on May 20 and over 260% on May...